193693-69-5 Usage
General Description
(S)-1-N-Cbz-3-cyanopyrrolidine is a chemical compound that belongs to the class of pyrrolidine derivatives. It is a chiral compound, with its stereochemistry designated as (S)-1. The "N-Cbz" in its name refers to the N-tert-butoxycarbonyl protecting group, which is commonly used in organic synthesis to protect the amine functionality. The "3-cyanopyrrolidine" portion indicates that there is a cyano group attached to the third carbon of the pyrrolidine ring. (S)-1-N-Cbz-3-cyanopyrrolidine has potential applications in organic synthesis and drug discovery, as the pyrrolidine scaffold is a common structural motif in pharmaceuticals and biologically active molecules. Its specific properties and uses may vary depending on the context and the specific reactions or applications it is being used for.
Check Digit Verification of cas no
The CAS Registry Mumber 193693-69-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,3,6,9 and 3 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 193693-69:
(8*1)+(7*9)+(6*3)+(5*6)+(4*9)+(3*3)+(2*6)+(1*9)=185
185 % 10 = 5
So 193693-69-5 is a valid CAS Registry Number.
193693-69-5Relevant articles and documents
CARBAPENEM ANTIBACTERIALS WITH GRAM-NEGATIVE ACTIVITY
-
Page/Page column 58-59, (2012/01/06)
The present invention provides β-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment.
PYRROLIDINE DERIVATIVES AS HISTAMINE RECEPTORS LIGANDS
-
Page/Page column 22-23, (2010/11/08)
The present invention relates to pyrrolidine derivatives of formula (I) having pharmacological activity, processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.
Synthesis of potent oxindole CDK2 inhibitors
Dermatakis, Apos,Luk, Kin-Chun,DePinto, Wanda
, p. 1873 - 1881 (2007/10/03)
A series of oxindole CDK2 inhibitors was synthesized. These novel analogues have a saturated monosubstituted cyclic moiety at their C-4 position that mimics the ribofuranoside of ATP. This substitution afforded agents with increased potency relative to th
